| Virginia Lee Vessecchia, LPN | |
|
21851 84th Ave S, Kent, WA 98032-1958 | |
| (425) 687-7082 | |
| Not Available |
| Full Name | Virginia Lee Vessecchia |
|---|---|
| Gender | Female |
| Speciality | Licensed Vocational Nurse |
| Location | 21851 84th Ave S, Kent, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023762390 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164X00000X | Licensed Vocational Nurse | LP60261031 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Virginia Lee Vessecchia, LPN 21851 84th Ave S, Kent, WA 98032-1958 Ph: () - | Virginia Lee Vessecchia, LPN 21851 84th Ave S, Kent, WA 98032-1958 Ph: (425) 687-7082 |
News Archive
Thanks to an innovative mosquito control approach developed at Rutgers University-New Brunswick, residents in several Maryland neighborhoods reduced populations of invasive Asian tiger mosquitoes by an impressive 76 percent, on average.
A woman's choice of surgeon plays a significant role in whether she's likely to receive an increasingly popular aggressive breast cancer surgery.
Amgen will present data from four Phase 2 trials of AMG 145, an investigational fully human monoclonal antibody directed against PCSK9, a protein that reduces the liver's ability to remove low density lipoprotein cholesterol, or "bad" cholesterol from the blood, at the upcoming American Heart Association Scientific Sessions 2012.
The fight to treat cancer and eradicate tumors will likely benefit from a new set of treatments if early development phases continue to show promise, according to Kalorama Information. The healthcare market research publisher stated that gene therapies that are able to deliver genetic material to a specific cell population or tumor that will result in the destruction of the tumor.
With the launch of the country's first ever commercial genetic test for type 2 diabetes, Indians will now have access to clinically relevant and cost effective genetic risk assessment services. NutraGene, a Delhi based genomics company that launched the tests believes that its type 2 diabetes genetic test will provide physicians an effective tool in assessing the risk of diabetes in the Indian population and will help in implementing personalized prevention and management strategies.
› Verified 5 days ago
Mrs. Blanchei Baloy Arreola, LP00057493 Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 4821 S Kent Des Moines Rd # B341, Kent, WA 98032 Phone: 425-899-3300 Fax: 425-899-1740 | |
Mr. Newton Sammy Nguyo, LPN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 6312 S 239th St Apt N301, Kent, WA 98032 Phone: 903-422-0148 Fax: 903-422-0148 |